font size
printPrint


Health: Regenerative Medicine

Subtopics:

REGENERATIVE MEDICINE:

Eye on the Prize

Geron's expectations for clinical trials that would transplant a type of neural stem cell into humans are modest, but success would validate a lengthy and costly effort.


Geron is on the verge of a first-of-its-kind clinical trial that entails transplanting a type of neural cell into spinal cord-injured patients. Though the Menlo Park, California-based company has said that before, Geron researchers now expect the long-awaited trial to begin in 2008. Anticipation remains strong, not only because of what the test could portend for spinal cord repair, but because success would represent, according to the company, the first time a product derived from embryonic stem cells has proved safe and effective for humans.

READ MORE.

 

  • A Mother's Dilemma    
    Parents must decide whether banking their child's cord blood could lead to a cure of a future disease or just be an expensive waste of time.
    October 25, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine
  • PHOTO ESSAY: A Mother's Dilemma    
    October 01, 2007 - JOAN SINCLAIR - Health - Regenerative Medicine
  • Money Changes Everything
    Stem cell measure draws top researchers to California through promise of funding.
    August 20, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine
  • At a Crossroads
    The public can either follow prescriptive guidance on the banking of cord blood stem cells or make its own informed decision.
    August 15, 2007 - STEPHEN M. GRANT - Health - Regenerative Medicine
  • Let Science Dictate Research
    Congress should help build on researchers' stem cell momentum.
    June 07, 2007 - JONATHAN C. MORENO and SAM BERGER - Health - Regenerative Medicine
  • A New Kind of Life Insurance
    California company offers personalized stem cells lines for patients of IVF clinics.
    June 02, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine
  • Case Closed
    California's stem cell chairman Robert Klein looks ahead after the state's top court squashes an effort to end funding for research.
    May 18, 2007 - Health - Regenerative Medicine
  • In A Pig's Islet
    Australian company ready to enter clinic with encapsulated pig cells.
    May 14, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Uncovering the Potential    
    September 01, 2007 - By David Gollaher - Policy - Regenerative Medicine
  • Why the Controversy Misses the Point    
    A focus on embryos and cures has obscured an invaluable research tool.
    September 01, 2007 - By Gareth Cook - Policy - Regulatory